PROFUND ADVISORS LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$3,251,000
+99.2%
38,237
-17.0%
0.17%
+83.5%
Q2 2020$1,632,000
+223.2%
46,055
+23.1%
0.09%
+139.5%
Q1 2020$505,000
-54.9%
37,427
-29.3%
0.04%
-22.4%
Q4 2019$1,119,000
+94.3%
52,904
+21.8%
0.05%
+69.0%
Q3 2019$576,000
-9.7%
43,424
-5.6%
0.03%
-3.3%
Q2 2019$638,000
-33.5%
46,005
-8.0%
0.03%
-34.8%
Q1 2019$960,000
+35.6%
49,988
+0.7%
0.05%
+4.5%
Q4 2018$708,000
-42.6%
49,647
-16.2%
0.04%
-6.4%
Q3 2018$1,234,00059,2220.05%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders